SMT201500001B - Anticorpi contro CTF-611 variante troncata di her2 - Google Patents

Anticorpi contro CTF-611 variante troncata di her2

Info

Publication number
SMT201500001B
SMT201500001B SM201500001T SM201500001T SMT201500001B SM T201500001 B SMT201500001 B SM T201500001B SM 201500001 T SM201500001 T SM 201500001T SM 201500001 T SM201500001 T SM 201500001T SM T201500001 B SMT201500001 B SM T201500001B
Authority
SM
San Marino
Prior art keywords
ctf
her2
antibodies against
truncated variant
truncated
Prior art date
Application number
SM201500001T
Other languages
English (en)
Italian (it)
Inventor
Lopez Joaquin Arribas
Kim Pedersen
Pier-Davide Angellini
Palau Josep Lluis Parra
Torres Josei Baselga
Original Assignee
Fundacio Privada Institucio Catalana De Recerca I Estudis Avancants
Fundacio Privada Inst D Investigacio Oncologica Devall Hebron
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacio Privada Institucio Catalana De Recerca I Estudis Avancants, Fundacio Privada Inst D Investigacio Oncologica Devall Hebron filed Critical Fundacio Privada Institucio Catalana De Recerca I Estudis Avancants
Publication of SMT201500001B publication Critical patent/SMT201500001B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SM201500001T 2009-12-07 2015-01-02 Anticorpi contro CTF-611 variante troncata di her2 SMT201500001B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09380183.5A EP2330131B1 (de) 2009-12-07 2009-12-07 Antikörper gegen die HER2-verkürzte Variante CTF-611

Publications (1)

Publication Number Publication Date
SMT201500001B true SMT201500001B (it) 2015-03-05

Family

ID=42077878

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201500001T SMT201500001B (it) 2009-12-07 2015-01-02 Anticorpi contro CTF-611 variante troncata di her2

Country Status (11)

Country Link
US (1) US8741586B2 (de)
EP (3) EP2330131B1 (de)
JP (1) JP5852306B2 (de)
CY (1) CY1115927T1 (de)
DK (1) DK2330131T3 (de)
ES (2) ES2527143T3 (de)
HR (1) HRP20141257T1 (de)
PL (1) PL2330131T3 (de)
PT (1) PT2330131E (de)
SI (1) SI2330131T1 (de)
SM (1) SMT201500001B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10416162B2 (en) 2007-12-20 2019-09-17 Monogram Biosciences, Inc. Her2 diagnostic methods
EP2438442B1 (de) 2008-12-01 2017-08-09 Laboratory Corporation of America Holdings Verfahren und tests zur messung von p95 und/oder p95-komlexen in einer probe und für p95 spezifische antikörper
WO2010132723A1 (en) * 2009-05-14 2010-11-18 Prometheus Laboratories Inc. Biomarkers for determining sensitivity of breast cancer cells to her2-targeted therapy
WO2013101964A1 (en) * 2011-12-27 2013-07-04 Kadmon Corporation, Llc Methods for treatment of breast cancer nonresponsive to trastuzumab
WO2015091738A1 (en) * 2013-12-20 2015-06-25 F. Hoffmann-La Roche Ag Bispecific her2 antibodies and methods of use
MA44334A (fr) 2015-10-29 2018-09-05 Novartis Ag Conjugués d'anticorps comprenant un agoniste du récepteur de type toll
EP3519437B1 (de) 2016-09-30 2021-09-08 F. Hoffmann-La Roche AG Bispezifiche antikörper gegen p95her2
JPWO2018116465A1 (ja) * 2016-12-22 2019-10-24 日立化成株式会社 Ｈｅｒ２陽性癌細胞の検出方法
AR111651A1 (es) 2017-04-28 2019-08-07 Novartis Ag Conjugados de anticuerpos que comprenden agonistas del receptor de tipo toll y terapias de combinación
AU2018383096A1 (en) * 2017-12-11 2020-06-11 Medizinische Universitaet Wien A method of producing a vaccine composition and uses thereof
CN110865184B (zh) * 2019-12-04 2023-04-07 广州医科大学附属第三医院（广州重症孕产妇救治中心、广州柔济医院） Srsp蛋白和srsp抗原表位肽的应用及诊断和治疗肿瘤的产品
EP3915576A1 (de) 2020-05-28 2021-12-01 Fundació Privada Institut d'Investigació Oncològica de Vall-Hebron Für p95her2 spezifische chimäre antigenrezeptoren und deren verwendung
WO2022114163A1 (ja) * 2020-11-30 2022-06-02 小野薬品工業株式会社 Ｈｅｒ２標的化剤
CN118556082A (zh) * 2022-01-26 2024-08-27 山东先声生物制药有限公司 p95HER2抗体及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989006692A1 (en) 1988-01-12 1989-07-27 Genentech, Inc. Method of treating tumor cells by inhibiting growth factor receptor function
ES2342646B1 (es) 2008-06-02 2011-04-26 Institut De Recerca Hospital Universitari Vall Hebron Metodo de diagnostico de canceres que expresan el receptor her-2 o sus variantes truncadas.
EP2438442B1 (de) * 2008-12-01 2017-08-09 Laboratory Corporation of America Holdings Verfahren und tests zur messung von p95 und/oder p95-komlexen in einer probe und für p95 spezifische antikörper

Also Published As

Publication number Publication date
PL2330131T3 (pl) 2015-05-29
PT2330131E (pt) 2015-01-14
EP3048117A1 (de) 2016-07-27
EP2360187A1 (de) 2011-08-24
JP5852306B2 (ja) 2016-02-03
EP2360187B1 (de) 2016-04-20
US20110135653A1 (en) 2011-06-09
HRP20141257T1 (en) 2015-03-13
JP2011121943A (ja) 2011-06-23
US8741586B2 (en) 2014-06-03
EP2330131B1 (de) 2014-10-08
DK2330131T3 (da) 2015-01-05
ES2527143T3 (es) 2015-01-20
ES2581627T3 (es) 2016-09-06
SI2330131T1 (sl) 2015-02-27
CY1115927T1 (el) 2017-01-25
EP2330131A1 (de) 2011-06-08

Similar Documents

Publication Publication Date Title
SMT201500001B (it) Anticorpi contro CTF-611 variante troncata di her2
LTC2579894I2 (lt) CGRP antikūnai
SMT201600008B (it) Composti di piridazinone
SMT201600222B (it) Formulazione di anticorpi
BRPI1011145A2 (pt) anticorpo anti-axl
DK2459167T3 (da) SUBKUTAN ANTI-HER2-antistofformulering
BRPI1006519A2 (pt) formulação de anticorpos
DK3323830T3 (da) Anti-gd2 antibodies
BR112012030311A2 (pt) anticorpo
BRPI1006572A2 (pt) bombas
DK2442771T3 (da) Silikone-arbehandlingspræparat
SMT201500203B (it) Proteina di fusione anticancro
IT1398296B1 (it) Disposizione di sensori
SMT201500268B (it) Derivato di 5-idrossipirimidin-4-carbossammide
FI20095644A (fi) Ulokkeen muodostaminen
ITTO20110268A1 (it) Composizione di maquillage.
SMT201400194B (it) Complesso di flurano
BRPI1014031A2 (pt) vacinas de nanoemulsão
FR2942638B1 (fr) Secteur angulaire de redresseur pour compresseur de turbomachine
BR112013010270A2 (pt) polimorfos de febuxostato
IT1394232B1 (it) Apparato di manipolazione di contenitori
IT1403062B1 (it) Metodo di piegatura di assorbenti igienici.
TH0901005583A (th) แอนติ-igf แอนติบอดี
DOP2010000206A (es) Her2 composiciones de anticuerpo
EE00879U1 (et) Piltm?istatuspramiid